Cooper Companies (NASDAQ:COO) Lifted to Buy at Redburn Atlantic

Cooper Companies (NASDAQ:COOGet Free Report) was upgraded by research analysts at Redburn Atlantic from a “neutral” rating to a “buy” rating in a report released on Tuesday, MarketBeat Ratings reports. The brokerage presently has a $125.00 price target on the medical device company’s stock. Redburn Atlantic’s price objective points to a potential upside of 22.96% from the company’s current price.

Several other research analysts also recently commented on COO. JPMorgan Chase & Co. raised Cooper Companies from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $100.00 to $120.00 in a report on Wednesday, March 13th. TheStreet downgraded Cooper Companies from a “b-” rating to a “c” rating in a research report on Thursday, February 29th. Morgan Stanley decreased their target price on Cooper Companies from $102.50 to $88.75 and set an “equal weight” rating on the stock in a report on Monday, December 4th. KeyCorp started coverage on Cooper Companies in a report on Tuesday, February 6th. They issued a “sector weight” rating for the company. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $110.00 price target (up previously from $105.00) on shares of Cooper Companies in a research report on Friday, March 1st. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $108.38.

Read Our Latest Stock Report on Cooper Companies

Cooper Companies Stock Performance

Cooper Companies stock opened at $101.66 on Tuesday. The firm has a market capitalization of $20.21 billion, a P/E ratio of 69.51, a P/E/G ratio of 2.53 and a beta of 0.93. The stock has a fifty day moving average price of $96.69 and a two-hundred day moving average price of $89.07. Cooper Companies has a 52-week low of $75.93 and a 52-week high of $104.07. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.86 and a quick ratio of 1.08.

Cooper Companies (NASDAQ:COOGet Free Report) last announced its earnings results on Thursday, February 29th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The business had revenue of $931.60 million during the quarter, compared to analysts’ expectations of $915.93 million. Cooper Companies had a net margin of 7.93% and a return on equity of 8.79%. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter last year, the company posted $2.90 EPS. As a group, analysts anticipate that Cooper Companies will post 3.54 EPS for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Gary S. Petersmeyer sold 600 shares of the firm’s stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $84.01, for a total transaction of $50,404.50. Following the transaction, the director now owns 9,188 shares in the company, valued at $771,860.91. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, Director Gary S. Petersmeyer sold 600 shares of the company’s stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $84.01, for a total value of $50,404.50. Following the completion of the sale, the director now owns 9,188 shares in the company, valued at approximately $771,860.91. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Gary S. Petersmeyer sold 1,000 shares of Cooper Companies stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $103.51, for a total value of $103,510.00. Following the transaction, the director now owns 5,668 shares in the company, valued at $586,694.68. The disclosure for this sale can be found here. In the last 90 days, insiders sold 56,324 shares of company stock worth $5,675,019. Insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Cooper Companies

Several institutional investors and hedge funds have recently modified their holdings of the business. Cary Street Partners Investment Advisory LLC acquired a new position in shares of Cooper Companies during the third quarter worth about $26,000. KB Financial Partners LLC bought a new stake in Cooper Companies in the 1st quarter valued at approximately $34,000. Clear Street Markets LLC boosted its position in Cooper Companies by 93.9% during the 1st quarter. Clear Street Markets LLC now owns 95 shares of the medical device company’s stock worth $35,000 after acquiring an additional 46 shares during the last quarter. Blue Trust Inc. grew its stake in shares of Cooper Companies by 54.8% during the 4th quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after acquiring an additional 34 shares in the last quarter. Finally, Lindbrook Capital LLC raised its holdings in shares of Cooper Companies by 182.5% in the fourth quarter. Lindbrook Capital LLC now owns 113 shares of the medical device company’s stock valued at $43,000 after purchasing an additional 73 shares during the last quarter. 96.31% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Analyst Recommendations for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.